Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 14 entries
Sorted by: Best Match Show Resources per page
[Clinical Guidelines 2.0: Translation of Tables 2 and 3 and Apendix 1 of Schünemann HJ et al. CMAJ. 2014; 186:E123-42].

Acta medica portuguesa

dos Santos GF, Azevedo PC, Vaz-Carneiro A.
PMID: 26421797
Acta Med Port. 2015 May-Jun;28(3):395-414. doi: 10.20344/amp.6602. Epub 2015 Jun 30.

Clinical Practice Guidelines are instruments to support decision to improve the quality of clinical care. An expert group from McMaster University (Canada) has developed - from high-quality literature sources - a guidance on the practical steps for their development,...

Cite
dos Santos GF, Azevedo PC, Vaz-Carneiro A. Normas de Orientação Clínica 2.0: Tradução das Tabelas 2 e 3 e do Apêndice 1 de Schünemann HJ et al. CMAJ. 2014; 186:E123-42. [Clinical Guidelines 2.0: Translation of Tables 2 and 3 and Apendix 1 of Schünemann HJ et al. CMAJ. 2014; 186:E123-42]. Acta Med Port. 2015;28(3):395-414doi: 10.20344/amp.6602.
dos Santos, G. F., Azevedo, P. C., & Vaz-Carneiro, A. (2015). Normas de Orientação Clínica 2.0: Tradução das Tabelas 2 e 3 e do Apêndice 1 de Schünemann HJ et al. CMAJ. 2014; 186:E123-42. [Clinical Guidelines 2.0: Translation of Tables 2 and 3 and Apendix 1 of Schünemann HJ et al. CMAJ. 2014; 186:E123-42]. Acta medica portuguesa, 28(3), 395-414. https://doi.org/10.20344/amp.6602
dos Santos, Guilherme Ferreira, et al. "Normas de Orientação Clínica 2.0: Tradução das Tabelas 2 e 3 e do Apêndice 1 de Schünemann HJ et al. CMAJ. 2014; 186:E123-42." [Clinical Guidelines 2.0: Translation of Tables 2 and 3 and Apendix 1 of Schünemann HJ et al. CMAJ. 2014; 186:E123-42]. Acta medica portuguesa vol. 28,3 (2015): 395-414. doi: https://doi.org/10.20344/amp.6602
dos Santos GF, Azevedo PC, Vaz-Carneiro A. Normas de Orientação Clínica 2.0: Tradução das Tabelas 2 e 3 e do Apêndice 1 de Schünemann HJ et al. CMAJ. 2014; 186:E123-42. [Clinical Guidelines 2.0: Translation of Tables 2 and 3 and Apendix 1 of Schünemann HJ et al. CMAJ. 2014; 186:E123-42]. Acta Med Port. 2015 May-Jun;28(3):395-414. doi: 10.20344/amp.6602. Epub 2015 Jun 30. Portuguese. PMID: 26421797.
Copy Download .nbib Format: NLM
Correction to the article "Excess Mortality Estimation During the COVID-19 Pandemic: Preliminary Data from Portugal", published on Acta Med Port 2020 Jun;33(6):376-383.

Acta medica portuguesa

Nogueira PJ, De Araújo Nobre M, Nicola PJ, Furtado C, Vaz Carneiro A.
PMID: 32504526
Acta Med Port. 2020 Jun 01;33(6):450-451. doi: 10.20344/amp.14041.

No abstract available.

Cite
Nogueira PJ, De Araújo Nobre M, Nicola PJ, et al. Correction to the article "Excess Mortality Estimation During the COVID-19 Pandemic: Preliminary Data from Portugal", published on Acta Med Port 2020 Jun;33(6):376-383. Acta Med Port. 2020;33(6):450-451doi: 10.20344/amp.14041.
Nogueira, P. J., De Araújo Nobre, M., Nicola, P. J., Furtado, C., & Vaz Carneiro, A. (2020). Correction to the article "Excess Mortality Estimation During the COVID-19 Pandemic: Preliminary Data from Portugal", published on Acta Med Port 2020 Jun;33(6):376-383. Acta medica portuguesa, 33(6), 450-451. https://doi.org/10.20344/amp.14041
Nogueira, Paulo Jorge, et al. "Correction to the article "Excess Mortality Estimation During the COVID-19 Pandemic: Preliminary Data from Portugal", published on Acta Med Port 2020 Jun;33(6):376-383." Acta medica portuguesa vol. 33,6 (2020): 450-451. doi: https://doi.org/10.20344/amp.14041
Nogueira PJ, De Araújo Nobre M, Nicola PJ, Furtado C, Vaz Carneiro A. Correction to the article "Excess Mortality Estimation During the COVID-19 Pandemic: Preliminary Data from Portugal", published on Acta Med Port 2020 Jun;33(6):376-383. Acta Med Port. 2020 Jun 01;33(6):450-451. doi: 10.20344/amp.14041. PMID: 32504526.
Copy Download .nbib Format: NLM
The burden of atherosclerosis in Portugal.

European heart journal. Quality of care & clinical outcomes

Costa J, Alarcão J, Araujo F, Ascenção R, Caldeira D, Fiorentino F, Gil V, Gouveia M, Lourenço F, Mello E Silva A, Sampaio F, Vaz Carneiro A, Borges M.
PMID: 32946553
Eur Heart J Qual Care Clin Outcomes. 2021 Mar 15;7(2):154-162. doi: 10.1093/ehjqcco/qcaa060.

AIMS: This article sought to estimate the burden of disease attributable to atherosclerosis in mainland Portugal in 2016.METHODS AND RESULTS: The burden of atherosclerosis was measured in disability-adjusted life years following the latest 2010 Global Burden of Disease (GBD)...

Cite
Costa J, Alarcão J, Araujo F, et al. The burden of atherosclerosis in Portugal. Eur Heart J Qual Care Clin Outcomes. 2021;7(2):154-162doi: 10.1093/ehjqcco/qcaa060.
Costa, J., Alarcão, J., Araujo, F., Ascenção, R., Caldeira, D., Fiorentino, F., Gil, V., Gouveia, M., Lourenço, F., Mello E Silva, A., Sampaio, F., Vaz Carneiro, A., & Borges, M. (2021). The burden of atherosclerosis in Portugal. European heart journal. Quality of care & clinical outcomes, 7(2), 154-162. https://doi.org/10.1093/ehjqcco/qcaa060
Costa, João, et al. "The burden of atherosclerosis in Portugal." European heart journal. Quality of care & clinical outcomes vol. 7,2 (2021): 154-162. doi: https://doi.org/10.1093/ehjqcco/qcaa060
Costa J, Alarcão J, Araujo F, Ascenção R, Caldeira D, Fiorentino F, Gil V, Gouveia M, Lourenço F, Mello E Silva A, Sampaio F, Vaz Carneiro A, Borges M. The burden of atherosclerosis in Portugal. Eur Heart J Qual Care Clin Outcomes. 2021 Mar 15;7(2):154-162. doi: 10.1093/ehjqcco/qcaa060. PMID: 32946553; PMCID: PMC7962771.
Copy Download .nbib Format: NLM
The Role of Health Preconditions on COVID-19 Deaths in Portugal: Evidence from Surveillance Data of the First 20293 Infection Cases.

Journal of clinical medicine

Nogueira PJ, de Araújo Nobre M, Costa A, Ribeiro RM, Furtado C, Bacelar Nicolau L, Camarinha C, Luís M, Abrantes R, Vaz Carneiro A.
PMID: 32722159
J Clin Med. 2020 Jul 24;9(8). doi: 10.3390/jcm9082368.

BACKGROUND: It is essential to study the effect of potential co-factors on the risk of death in patients infected by COVID-19. The identification of risk factors is important to allow more efficient public health and health services strategic interventions...

Cite
Nogueira PJ, de Araújo Nobre M, Costa A, et al. The Role of Health Preconditions on COVID-19 Deaths in Portugal: Evidence from Surveillance Data of the First 20293 Infection Cases. J Clin Med. 2020;9(8)doi: 10.3390/jcm9082368.
Nogueira, P. J., de Araújo Nobre, M., Costa, A., Ribeiro, R. M., Furtado, C., Bacelar Nicolau, L., Camarinha, C., Luís, M., Abrantes, R., & Vaz Carneiro, A. (2020). The Role of Health Preconditions on COVID-19 Deaths in Portugal: Evidence from Surveillance Data of the First 20293 Infection Cases. Journal of clinical medicine, 9(8), . https://doi.org/10.3390/jcm9082368
Nogueira, Paulo Jorge, et al. "The Role of Health Preconditions on COVID-19 Deaths in Portugal: Evidence from Surveillance Data of the First 20293 Infection Cases." Journal of clinical medicine vol. 9,8 (2020). doi: https://doi.org/10.3390/jcm9082368
Nogueira PJ, de Araújo Nobre M, Costa A, Ribeiro RM, Furtado C, Bacelar Nicolau L, Camarinha C, Luís M, Abrantes R, Vaz Carneiro A. The Role of Health Preconditions on COVID-19 Deaths in Portugal: Evidence from Surveillance Data of the First 20293 Infection Cases. J Clin Med. 2020 Jul 24;9(8). doi: 10.3390/jcm9082368. PMID: 32722159; PMCID: PMC7464004.
Copy Download .nbib Format: NLM
Cost and Burden Of Hypercholesterolemia In Portugal.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Gouveia M, Borges M, Augusto M, Caldeira D, Alarcão J, Pinheiro L, Sousa R, Fareleira F, Ascenção R, Costa J, Laires P, Fiuza M, Dias NC, Martins S, Belo A, Vaz-Carneiro A.
PMID: 27200619
Value Health. 2014 Nov;17(7):A339. doi: 10.1016/j.jval.2014.08.668. Epub 2014 Oct 26.

No abstract available.

Cite
Gouveia M, Borges M, Augusto M, et al. Cost and Burden Of Hypercholesterolemia In Portugal. Value Health. 2014;17(7):A339doi: 10.1016/j.jval.2014.08.668.
Gouveia, M., Borges, M., Augusto, M., Caldeira, D., Alarcão, J., Pinheiro, L., Sousa, R., Fareleira, F., Ascenção, R., Costa, J., Laires, P., Fiuza, M., Dias, N. C., Martins, S., Belo, A., & Vaz-Carneiro, A. (2014). Cost and Burden Of Hypercholesterolemia In Portugal. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A339. https://doi.org/10.1016/j.jval.2014.08.668
Gouveia, M, et al. "Cost and Burden Of Hypercholesterolemia In Portugal." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A339. doi: https://doi.org/10.1016/j.jval.2014.08.668
Gouveia M, Borges M, Augusto M, Caldeira D, Alarcão J, Pinheiro L, Sousa R, Fareleira F, Ascenção R, Costa J, Laires P, Fiuza M, Dias NC, Martins S, Belo A, Vaz-Carneiro A. Cost and Burden Of Hypercholesterolemia In Portugal. Value Health. 2014 Nov;17(7):A339. doi: 10.1016/j.jval.2014.08.668. Epub 2014 Oct 26. PMID: 27200619.
Copy Download .nbib Format: NLM
[Generalization of the results of clinical studies through the analysis of subgroups].

Acta medica portuguesa

Costa J, Fareleira F, Ascensão R, Vaz Carneiro A.
PMID: 22883248
Acta Med Port. 2012 Jan-Feb;25(1):44-50. Epub 2012 May 25.

Subgroup analysis in clinical trials are usually performed to define the potential heterogeneity of treatment effect in relation with the baseline risk, physiopathology, practical application of therapy or the under-utilization in clinical practice of effective interventions due to uncertainties...

Cite
Costa J, Fareleira F, Ascensão R, et al. A Generalização dos Resultados de Estudos Clínicos Através da Análise de Subgrupos. [Generalization of the results of clinical studies through the analysis of subgroups]. Acta Med Port. 2012;25(1):44-50
Costa, J., Fareleira, F., Ascensão, R., & Vaz Carneiro, A. (2012). A Generalização dos Resultados de Estudos Clínicos Através da Análise de Subgrupos. [Generalization of the results of clinical studies through the analysis of subgroups]. Acta medica portuguesa, 25(1), 44-50.
Costa, João, et al. "A Generalização dos Resultados de Estudos Clínicos Através da Análise de Subgrupos." [Generalization of the results of clinical studies through the analysis of subgroups]. Acta medica portuguesa vol. 25,1 (2012): 44-50.
Costa J, Fareleira F, Ascensão R, Vaz Carneiro A. A Generalização dos Resultados de Estudos Clínicos Através da Análise de Subgrupos. [Generalization of the results of clinical studies through the analysis of subgroups]. Acta Med Port. 2012 Jan-Feb;25(1):44-50. Epub 2012 May 25. Portuguese. PMID: 22883248.
Copy Download .nbib Format: NLM
Lost in transition: a systematic review of the association between unemployment and mental health.

Journal of mental health (Abingdon, England)

Virgolino A, Costa J, Santos O, Pereira ME, Antunes R, Ambrósio S, Heitor MJ, Vaz Carneiro A.
PMID: 34983292
J Ment Health. 2022 Jan 05;1-13. doi: 10.1080/09638237.2021.2022615. Epub 2022 Jan 05.

BACKGROUND: Unemployment can involve financial strain and major psychosocial challenges. Integration of the existing evidence is needed to better characterize the association between unemployment and mental health, independently of macroeconomic contexts.AIMS: Main objectives of this study: (a) review, integrate,...

Cite
Virgolino A, Costa J, Santos O, et al. Lost in transition: a systematic review of the association between unemployment and mental health. J Ment Health. 2022;1-13doi: 10.1080/09638237.2021.2022615.
Virgolino, A., Costa, J., Santos, O., Pereira, M. E., Antunes, R., Ambrósio, S., Heitor, M. J., & Vaz Carneiro, A. (2022). Lost in transition: a systematic review of the association between unemployment and mental health. Journal of mental health (Abingdon, England), 1-13. https://doi.org/10.1080/09638237.2021.2022615
Virgolino, Ana, et al. "Lost in transition: a systematic review of the association between unemployment and mental health." Journal of mental health (Abingdon, England) vol. (2022): 1-13. doi: https://doi.org/10.1080/09638237.2021.2022615
Virgolino A, Costa J, Santos O, Pereira ME, Antunes R, Ambrósio S, Heitor MJ, Vaz Carneiro A. Lost in transition: a systematic review of the association between unemployment and mental health. J Ment Health. 2022 Jan 05;1-13. doi: 10.1080/09638237.2021.2022615. Epub 2022 Jan 05. PMID: 34983292.
Copy Download .nbib Format: NLM
[Analysis of the Cochrane Review: Antiplatelet Agents for Preventing Pre-Eclampsia and Its Complications. Cochrane Database Syst Rev. 2019;10:CD004659.].

Acta medica portuguesa

Reis de Carvalho C, Bigotte Vieira M, Costa J, Vaz Carneiro A.
PMID: 34989670
Acta Med Port. 2021 Dec 02;34(12):810-814. doi: 10.20344/amp.15995. Epub 2021 Dec 02.

Pre-eclampsia is associated with deficient intravascular production of prostacyclin, a vasodilator, and excessive production of thromboxane, a vasoconstrictor and stimulant of platelet aggregation. These observations led to the hypotheses that antiplatelet agents, low-dose aspirin in particular, might prevent or...

Cite
Reis de Carvalho C, Bigotte Vieira M, Costa J, et al. Análise da Revisão Cochrane: O Papel dos Antiagregantes Plaquetários para Prevenir a Pré-Eclâmpsia e as Suas Complicações. Cochrane Database Syst Rev. 2019;10:CD004659. [Analysis of the Cochrane Review: Antiplatelet Agents for Preventing Pre-Eclampsia and Its Complications. Cochrane Database Syst Rev. 2019;10:CD004659.]. Acta Med Port. 2021;34(12):810-814doi: 10.20344/amp.15995.
Reis de Carvalho, C., Bigotte Vieira, M., Costa, J., & Vaz Carneiro, A. (2021). Análise da Revisão Cochrane: O Papel dos Antiagregantes Plaquetários para Prevenir a Pré-Eclâmpsia e as Suas Complicações. Cochrane Database Syst Rev. 2019;10:CD004659. [Analysis of the Cochrane Review: Antiplatelet Agents for Preventing Pre-Eclampsia and Its Complications. Cochrane Database Syst Rev. 2019;10:CD004659.]. Acta medica portuguesa, 34(12), 810-814. https://doi.org/10.20344/amp.15995
Reis de Carvalho, Catarina, et al. "Análise da Revisão Cochrane: O Papel dos Antiagregantes Plaquetários para Prevenir a Pré-Eclâmpsia e as Suas Complicações. Cochrane Database Syst Rev. 2019;10:CD004659." [Analysis of the Cochrane Review: Antiplatelet Agents for Preventing Pre-Eclampsia and Its Complications. Cochrane Database Syst Rev. 2019;10:CD004659.]. Acta medica portuguesa vol. 34,12 (2021): 810-814. doi: https://doi.org/10.20344/amp.15995
Reis de Carvalho C, Bigotte Vieira M, Costa J, Vaz Carneiro A. Análise da Revisão Cochrane: O Papel dos Antiagregantes Plaquetários para Prevenir a Pré-Eclâmpsia e as Suas Complicações. Cochrane Database Syst Rev. 2019;10:CD004659. [Analysis of the Cochrane Review: Antiplatelet Agents for Preventing Pre-Eclampsia and Its Complications. Cochrane Database Syst Rev. 2019;10:CD004659.]. Acta Med Port. 2021 Dec 02;34(12):810-814. doi: 10.20344/amp.15995. Epub 2021 Dec 02. Portuguese. PMID: 34989670.
Copy Download .nbib Format: NLM
[Analysis of the Cochrane Review: Antiplatelet Agents for Preventing Pre-Eclampsia and Its Complications. Cochrane Database Syst Rev. 2019;10:CD004659.].

Acta medica portuguesa

Reis de Carvalho C, Bigotte Vieira M, Costa J, Vaz Carneiro A.
PMID: 34989670
Acta Med Port. 2021 Dec 02;34(12):810-814. doi: 10.20344/amp.15995. Epub 2021 Dec 02.

Pre-eclampsia is associated with deficient intravascular production of prostacyclin, a vasodilator, and excessive production of thromboxane, a vasoconstrictor and stimulant of platelet aggregation. These observations led to the hypotheses that antiplatelet agents, low-dose aspirin in particular, might prevent or...

Cite
Reis de Carvalho C, Bigotte Vieira M, Costa J, et al. Análise da Revisão Cochrane: O Papel dos Antiagregantes Plaquetários para Prevenir a Pré-Eclâmpsia e as Suas Complicações. Cochrane Database Syst Rev. 2019;10:CD004659. [Analysis of the Cochrane Review: Antiplatelet Agents for Preventing Pre-Eclampsia and Its Complications. Cochrane Database Syst Rev. 2019;10:CD004659.]. Acta Med Port. 2021;34(12):810-814doi: 10.20344/amp.15995.
Reis de Carvalho, C., Bigotte Vieira, M., Costa, J., & Vaz Carneiro, A. (2021). Análise da Revisão Cochrane: O Papel dos Antiagregantes Plaquetários para Prevenir a Pré-Eclâmpsia e as Suas Complicações. Cochrane Database Syst Rev. 2019;10:CD004659. [Analysis of the Cochrane Review: Antiplatelet Agents for Preventing Pre-Eclampsia and Its Complications. Cochrane Database Syst Rev. 2019;10:CD004659.]. Acta medica portuguesa, 34(12), 810-814. https://doi.org/10.20344/amp.15995
Reis de Carvalho, Catarina, et al. "Análise da Revisão Cochrane: O Papel dos Antiagregantes Plaquetários para Prevenir a Pré-Eclâmpsia e as Suas Complicações. Cochrane Database Syst Rev. 2019;10:CD004659." [Analysis of the Cochrane Review: Antiplatelet Agents for Preventing Pre-Eclampsia and Its Complications. Cochrane Database Syst Rev. 2019;10:CD004659.]. Acta medica portuguesa vol. 34,12 (2021): 810-814. doi: https://doi.org/10.20344/amp.15995
Reis de Carvalho C, Bigotte Vieira M, Costa J, Vaz Carneiro A. Análise da Revisão Cochrane: O Papel dos Antiagregantes Plaquetários para Prevenir a Pré-Eclâmpsia e as Suas Complicações. Cochrane Database Syst Rev. 2019;10:CD004659. [Analysis of the Cochrane Review: Antiplatelet Agents for Preventing Pre-Eclampsia and Its Complications. Cochrane Database Syst Rev. 2019;10:CD004659.]. Acta Med Port. 2021 Dec 02;34(12):810-814. doi: 10.20344/amp.15995. Epub 2021 Dec 02. Portuguese. PMID: 34989670.
Copy Download .nbib Format: NLM
The Place of Dpp-4 Inhibitors in the Treatment Algorithm of Diabetes Type 2: A Systematic Review of Cost-Effectiveness Studies.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Baptista A, Teixeira I, Romano S, Vaz CA, Perelman J.
PMID: 27200662
Value Health. 2014 Nov;17(7):A347-8. doi: 10.1016/j.jval.2014.08.712. Epub 2014 Oct 26.

No abstract available.

Cite
Baptista A, Teixeira I, Romano S, et al. The Place of Dpp-4 Inhibitors in the Treatment Algorithm of Diabetes Type 2: A Systematic Review of Cost-Effectiveness Studies. Value Health. 2014;17(7):A347-8doi: 10.1016/j.jval.2014.08.712.
Baptista, A., Teixeira, I., Romano, S., Vaz, C. A., & Perelman, J. (2014). The Place of Dpp-4 Inhibitors in the Treatment Algorithm of Diabetes Type 2: A Systematic Review of Cost-Effectiveness Studies. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A347-8. https://doi.org/10.1016/j.jval.2014.08.712
Baptista, A, et al. "The Place of Dpp-4 Inhibitors in the Treatment Algorithm of Diabetes Type 2: A Systematic Review of Cost-Effectiveness Studies." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A347-8. doi: https://doi.org/10.1016/j.jval.2014.08.712
Baptista A, Teixeira I, Romano S, Vaz CA, Perelman J. The Place of Dpp-4 Inhibitors in the Treatment Algorithm of Diabetes Type 2: A Systematic Review of Cost-Effectiveness Studies. Value Health. 2014 Nov;17(7):A347-8. doi: 10.1016/j.jval.2014.08.712. Epub 2014 Oct 26. PMID: 27200662.
Copy Download .nbib Format: NLM
Cochrane Sustainable Healthcare: evidence for action on too much medicine.

The Cochrane database of systematic reviews

Johansson M, Bero L, Bonfill X, Bruschettini M, Garner S, Glenton C, Harris R, Jørgensen KJ, Levinson W, Lotfi T, Montori V, Meng DM, Schünemann H, Vaz Carneiro A, Woloshin S, Moynihan R.
PMID: 31808554
Cochrane Database Syst Rev. 2019 Dec 06;12:ED000143. doi: 10.1002/14651858.ED000143.

No abstract available.

Cite
Johansson M, Bero L, Bonfill X, et al. Cochrane Sustainable Healthcare: evidence for action on too much medicine. Cochrane Database Syst Rev. 2019;12:ED000143doi: 10.1002/14651858.ED000143.
Johansson, M., Bero, L., Bonfill, X., Bruschettini, M., Garner, S., Glenton, C., Harris, R., Jørgensen, K. J., Levinson, W., Lotfi, T., Montori, V., Meng, D. M., Schünemann, H., Vaz Carneiro, A., Woloshin, S., & Moynihan, R. (2019). Cochrane Sustainable Healthcare: evidence for action on too much medicine. The Cochrane database of systematic reviews, 12ED000143. https://doi.org/10.1002/14651858.ED000143
Johansson, Minna, et al. "Cochrane Sustainable Healthcare: evidence for action on too much medicine." The Cochrane database of systematic reviews vol. 12 (2019): ED000143. doi: https://doi.org/10.1002/14651858.ED000143
Johansson M, Bero L, Bonfill X, Bruschettini M, Garner S, Glenton C, Harris R, Jørgensen KJ, Levinson W, Lotfi T, Montori V, Meng DM, Schünemann H, Vaz Carneiro A, Woloshin S, Moynihan R. Cochrane Sustainable Healthcare: evidence for action on too much medicine. Cochrane Database Syst Rev. 2019 Dec 06;12:ED000143. doi: 10.1002/14651858.ED000143. PMID: 31808554.
Copy Download .nbib Format: NLM
Missed opportunities in health care education evidence synthesis.

Medical education

Gordon M, Vaz Carneiro A, Patricio M, Gibbs T.
PMID: 24807440
Med Educ. 2014 Jun;48(6):644-5. doi: 10.1111/medu.12478.

No abstract available.

Cite
Gordon M, Vaz Carneiro A, Patricio M, et al. Missed opportunities in health care education evidence synthesis. Med Educ. 2014;48(6):644-5doi: 10.1111/medu.12478.
Gordon, M., Vaz Carneiro, A., Patricio, M., & Gibbs, T. (2014). Missed opportunities in health care education evidence synthesis. Medical education, 48(6), 644-5. https://doi.org/10.1111/medu.12478
Gordon, Morris, et al. "Missed opportunities in health care education evidence synthesis." Medical education vol. 48,6 (2014): 644-5. doi: https://doi.org/10.1111/medu.12478
Gordon M, Vaz Carneiro A, Patricio M, Gibbs T. Missed opportunities in health care education evidence synthesis. Med Educ. 2014 Jun;48(6):644-5. doi: 10.1111/medu.12478. PMID: 24807440.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 14 entries